Literature DB >> 19332391

Circadian patterns in the occurrence of malignant ventricular tachyarrhythmias triggering defibrillator interventions in patients with hypertrophic cardiomyopathy.

Barry J Maron1, Christopher Semsarian, Win-Kuang Shen, Mark S Link, Andrew E Epstein, N A Mark Estes, Adrian Almquist, Michael C Giudici, Tammy S Haas, James S Hodges, Paolo Spirito.   

Abstract

BACKGROUND: Sudden death in hypertrophic cardiomyopathy (HCM) has been reported to occur most frequently in the early morning hours, similar to the pattern observed in ischemic heart disease. However, little is known about the circadian pattern of life-threatening arrhythmias in HCM in the contemporary era of the implantable cardioverter-defibrillator (ICD).
OBJECTIVE: The purpose of this study was to determine the time of day when appropriate device interventions occur for ventricular tachycardia (VT)/ventricular fibrillation (VF) in HCM patients.
METHODS: Among 63 patients with HCM and appropriate device interventions, 126 intracardiac electrograms were assessed for the hourly distribution of VT/VF.
RESULTS: One or more arrhythmic episodes occurred in each hour of the day, and a modest pattern of circadian variability was evident. VT/VF episodes were more common in the afternoon and evening hours from noon to midnight (64%) than in the other 12-hour period (36%; P = .008), with the suggestion of a peak at 2 to 4 PM. A sizeable proportion of events (27%) occurred during the potential sleeping hours of 11 PM and 7 AM.
CONCLUSION: In high-risk HCM patients, the afternoon and evening circadian periodicity of ventricular tachyarrhythmias (terminated by the ICD) underscores the largely unpredictable nature of the electrophysiologic substrate in this disease, and differs from the pattern of early morning cardiovascular events reported in ischemic heart disease. These observations also suggest that home automatic defibrillator strategies for sudden death prevention are unlikely to be effective in HCM.

Entities:  

Mesh:

Year:  2009        PMID: 19332391     DOI: 10.1016/j.hrthm.2009.02.007

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  10 in total

Review 1.  Sleep-disordered breathing in hypertrophic cardiomyopathy: challenges and opportunities.

Authors:  Tomas Konecny; Virend K Somers
Journal:  Chest       Date:  2014-07       Impact factor: 9.410

2.  Hypertrophic cardiomyopathy and sudden cardiac death.

Authors:  Konstantinos I Stroumpoulis; Ioannis N Pantazopoulos; Theodoros T Xanthos
Journal:  World J Cardiol       Date:  2010-09-26

3.  Fibrosis and wall thickness affect ventricular repolarization dynamics in hypertrophic cardiomyopathy.

Authors:  Mikko Jalanko; Heikki Väänänen; Mika Tarkiainen; Petri Sipola; Pertti Jääskeläinen; Kirsi Lauerma; Tiina Laitinen; Tomi Laitinen; Mika Laine; Tiina Heliö; Johanna Kuusisto; Matti Viitasalo
Journal:  Ann Noninvasive Electrocardiol       Date:  2018-07-04       Impact factor: 1.468

Review 4.  Sudden death in hypertrophic cardiomyopathy.

Authors:  Barry J Maron
Journal:  J Cardiovasc Transl Res       Date:  2009-11-13       Impact factor: 4.132

5.  Myofilament protein dynamics modulate EAD formation in human hypertrophic cardiomyopathy.

Authors:  Melanie A Zile; Natalia A Trayanova
Journal:  Prog Biophys Mol Biol       Date:  2017-06-22       Impact factor: 3.667

6.  Circadian Variation of Ventricular Arrhythmias in Catecholaminergic Polymorphic Ventricular Tachycardia.

Authors:  Christina Y Miyake; S Yukiko Asaki; Gregory Webster; Richard J Czosek; Joseph Atallah; Kishor Avasarala; Sri O Rao; Patricia E Thomas; Jeffrey J Kim; Santiago O Valdes; Caridad de la Uz; Yunfei Wang; Xander H T Wehrens; Dominic Abrams
Journal:  JACC Clin Electrophysiol       Date:  2017-08-30

Review 7.  Sudden Cardiac Death in the Young.

Authors:  Michael Ackerman; Dianne L Atkins; John K Triedman
Journal:  Circulation       Date:  2016-03-08       Impact factor: 29.690

8.  Unexpected deviation in circadian variation of ventricular arrhythmias: the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).

Authors:  Kristen K Patton; Anne S Hellkamp; Kerry L Lee; Daniel B Mark; George W Johnson; Jill Anderson; Gust H Bardy; Jeanne E Poole
Journal:  J Am Coll Cardiol       Date:  2014-04-16       Impact factor: 24.094

9.  Circadian networks in human embryonic stem cell-derived cardiomyocytes.

Authors:  Pieterjan Dierickx; Marit W Vermunt; Mauro J Muraro; Menno P Creyghton; Pieter A Doevendans; Alexander van Oudenaarden; Niels Geijsen; Linda W Van Laake
Journal:  EMBO Rep       Date:  2017-05-23       Impact factor: 8.807

Review 10.  Percutaneous Septal Ablation in Hypertrophic Obstructive Cardiomyopathy: From Experiment to Standard of Care.

Authors:  Lothar Faber
Journal:  Adv Med       Date:  2014-05-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.